Bevacizumab monoclonal antibody drug. Angiogenesis inhibitor targeting VEGF-A, used to treat cancer and age-related macular degeneration (AMD). Gener

---

Bevacizumab monoclonal antibody drug. Angiogenesis inhibitor targeting VEGF-A, used to treat cancer and age-related macular degeneration (AMD). Generic name and stylized antibody.

---

Size: 9000px × 3274px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: -label, age, amd, angiogenesis, antibody, bevacizumab, biological, biosimilar, biotech, biotechnology, blood, breast, cancer, colorectal, degeneration, disease, drug, endothelial, eye, factor, growth, humanized, immunoglobulin, immunology, infusion, injection, inn, intravitreal, lung, mab, macular, monoclonal, neovascular, nomenclature, oncology, ophthalmologist, ophthalmology, peptide, protein, recombinant, related, tumor, vascular, vessel, vitreous